Amoxycillin + Clavulanic Acid in pharma franchise in Patna

Amoxycillin + Clavulanic Acid in PCD pharma franchise in Meerut

Amoxycillin + Clavulanic Acid in top pharma company in Sikkim

Amoxycillin + Clavulanic Acid In pcd pharma supplier in Gwalior

Amoxycillin + Clavulanic Acid in phama franchise company in India
Amoxycillin + Clavulanic Acid in phama distributor in Itanagar

Home/Products /amoxycillin-400mg-5ml-clavulanic-acid-57mg-5ml-dry-syrup

Moxyplit CV 457 Dry Syrup

Composition : Amoxycillin (400mg/5ml) + Clavulanic Acid (57mg/5ml)

Dosage Form : Dry Syrup

Packaging Type : Pet with Water

Packaging : 30 ml

Price : ₹149/-

Moxyplit CV 457 Dry Syrup is an antibiotic used to treat bacterial infections in areas such as the ear, nose, throat, chest, lungs, teeth, skin, and urinary tract. It is particularly effective against bacteria that have become resistant to other treatments, making it a valuable option for certain cases of tuberculosis that don’t respond to standard therapies.

Moxyplit CV 457 Dry Syrup can be given with or without food, although administering it with food may enhance absorption and reduce the risk of stomach upset. Your doctor may recommend giving it two to three times daily. The dosage is carefully determined based on the infection type, severity, and your child’s weight and age. Follow the dose, timing, and method as prescribed. If your child vomits within 30 minutes of taking the dose, allow time to settle before giving it again if necessary. Avoid a double dose if it’s close to the next scheduled time.


Inform your doctor about your child’s medical history, including any known allergies, heart conditions, blood disorders, congenital issues, airway or lung concerns, gastrointestinal problems, skin conditions, or liver or kidney impairments. This will help the doctor adjust the dosage and create an effective treatment plan tailored to your child’s needs.

Read More

About the Product

Moxyplit CV 457 Dry Syrup is an antibiotic used to treat bacterial infections in areas such as the ear, nose, throat, chest, lungs, teeth, skin, and urinary tract. It is particularly effective against bacteria that have become resistant to other treatments, making it a valuable option for certain cases of tuberculosis that don’t respond to standard therapies.

Moxyplit CV 457 Dry Syrup can be given with or without food, although administering it with food may enhance absorption and reduce the risk of stomach upset. Your doctor may recommend giving it two to three times daily. The dosage is carefully determined based on the infection type, severity, and your child’s weight and age. Follow the dose, timing, and method as prescribed. If your child vomits within 30 minutes of taking the dose, allow time to settle before giving it again if necessary. Avoid a double dose if it’s close to the next scheduled time.


Inform your doctor about your child’s medical history, including any known allergies, heart conditions, blood disorders, congenital issues, airway or lung concerns, gastrointestinal problems, skin conditions, or liver or kidney impairments. This will help the doctor adjust the dosage and create an effective treatment plan tailored to your child’s needs.

Possible side effects of Moxyplit CV 457 Dry Syrup include nausea, diarrhea, abdominal pain, vomiting, and mild allergic reactions. These symptoms usually resolve on their own, but consult your doctor if they persist or become uncomfortable for your child.

Moxyplit CV 457 Dry Syrup Prescribed for treating bacterial infections in the ear, nose, throat, lungs, skin, urinary tract, and certain drug-resistant tuberculosis cases.

Information regarding the use of Moxyplit CV 457 Dry Syrup during breastfeeding is not available. Please consult your doctor.

Store in a cool, dry place at room temperature. After reconstitution, the syrup should be used within the recommended time frame as indicated by the manufacturer.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation